(January 7, 2020, 1:40 PM EST) -- NEW YORK — Plaintiffs’ counsel on Jan. 6 said in a press release that Teva Pharmaceuticals Inc. agreed to pay $54 million to settle a whistle-blower lawsuit alleging that the drug maker paid bogus speaker fees to doctors to induce them to prescribe drugs for Parkinson’s disease and multiple sclerosis (United States ex rel. Charles Arnstein, et al. v. Teva Pharmaceuticals USA, Inc., et al., No. 13-3703, S.D. N.Y.)....